San Diego, CA /PRNewswire/ -- Bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) MicroConstants announced today the successful completion of a five-day inspection by the United States Food and Drug Administration (FDA) for compliance with Good Laboratory Practice (GLP) regulations.
On September 20, 2012, an investigator from the FDA visited MicroConstants' San Diego facility for a routine inspection to assess the CRO's overall compliance with GLP regulations. During the visit, the investigator toured the facility and laboratory areas and reviewed several method validations, three sample analysis projects, and a pharmacokinetic analysis report. Upon completion of the inspection, the investigator reported zero findings, observations, or recommendations.
SAN FRANCISCO--(BUSINESS WIRE)--
PRC Clinical™, a Contract Research Organization (CRO) in the San Francisco Bay Area providing full-service clinical trial management services, announced today that it has been awarded a Phase IIb study in an orphan-status therapeutic indication. Enrollment is expected at more than 50 study centers in the US and Canada.
Research Triangle Park – Copernicus Group IRB (CGIRB), a leading independent institutional review board, announced today that Corporate Trainer Sydney Douglas will be speaking at this week’s Barnett Clinical Summit in Cambridge, Mass.
The four-day summit, which begins today, is a premier information-sharing forum covering issues of key importance to clinical research professionals. The event includes formal presentations from leading experts, case studies, breakout discussion groups and workshops.
Lancaster, PA - Eurofins Lancaster Laboratories has launched a new validated Rapid Mycoplasma Detection Test, overcoming time-consuming challenges of the standard 28-day compendial method for mycoplasma testing. For GMP and non-GMP assays, Eurofins Lancaster Laboratories can now deliver same-day preliminary results, while ensuring rapid, robust and reliable culture-free mycoplasma detection that is less prone to matrix interferences. To execute this rapid technology, Eurofins Lancaster Laboratories uses EMD Millipore’s MilliPROBE® Real Time Detection System for Mycoplasma.
Princeton, N.J. - Sitrof Technologies, a leading provider of unstructured content management solutions for the Life Sciences industry, announces the next evolution in electronic Trial Master File management: eTMF in a secure, validated cloud.
Available for demonstration in Booth 3231 at this month’s DIA 2012 Annual Meeting in Philadelphia, Sitrof’s cloud eTMF solution is hosted on private servers in a 100 percent secure, redundant data center.
The commitment and investment in providing clients with the highest quality preclinical study data continues at SNBL
SNBL USA, contract research organization and the leader in NHP experience and expertise, announced it is on track with the implementation and launch of Instem’s Provantis® preclinical software solution suite in November 2012. SNBL USA will be using the flexible Provantis solution suite as its official data collection system, demonstrating the Company’s on-going commitment to offer biotechnology and pharmaceutical clients unparalleled quality in both science and service.
Advance Oncology Research with the Dual Expertise of Charles River and Metabolon
Charles River Discovery Services is partnering with Metabolon to better meet oncology research needs. Through this collaboration, Charles River’s preclinical oncology study expertise can be leveraged with Metabolon’s in-depth analysis of metabolic data to identify both mechanism of action and biomarkers.
Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won two awards at the PharmaTimes Annual Awards 2011 ceremony held February 16, 2012 at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.
BASi (NASDAQ:BASI) has opened its new Discovery Center, located at its corporate headquarters in the Purdue Research Park of West Lafayette. The purpose-built facility is designed to provide pharmaceutical and biotech companies with the information they need to evaluate new compounds in the earliest stages of development.
Want more? Visit...